Loading...
Loading...
- Pulmatrix Inc PULM shares surged 53 percent to $3.58. Pulmatrix shares have dropped 20.95 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
- Diffusion Pharmaceuticals Inc DFFN shares jumped 52.2 percent to $3.73.
- NantHealth Inc NH shares climbed 25 percent to $6.32.
- Caladrius Biosciences Inc CLBS shares jumped 23 percent to $6.27 after the company posted upbeat Q4 results.
- Norsat International Inc (USA) NSAT surged 17.4 percent to $9.45 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.
- AveXis Inc AVXS gained 16.6 percent to $84.89 after the company reported topline data from Phase 1 trial of AVXS-101.
-
Arbutus Biopharma Corp ABUS surged 14.9 percent to $3.28 after the company disclosed that it has licensed LNP delivery technology to Alexion Pharmaceuticals, Inc. ALXN for use in single messenger RNA product candidate.
- Agile Therapeutics Inc AGRX shares rose 14.5 percent to $3.08.
- Smart Sand Inc SND gained 13.2 percent to $16.43. Johnson Rice upgraded Smart Sand from Buy to Accumulate and raised the price target from $20.00 to $21.00.
- Adobe Systems Incorporated ADBE shares climbed 5.2 percent to $128.76 after the company reported better-than-expected results for its first quarter and issued a strong forecast for the current quarter. Wunderlich upgraded Adobe from Hold to Buy.
- Five9 Inc FIVN rose 4.6 percent to $17.60. Pacific Crest upgraded Five9 from Sector Weight to Overweight.
- Steel Dynamics, Inc. STLD gained 4.6 percent to $37.05. Steel Dynamics expects Q1 earnings of $0.77 to $0.81 per diluted share. The company also declared a quarterly cash dividend of $0.1550 per common share.
- Texas Roadhouse Inc TXRH rose 3.5 percent to $44.29. BTIG Research upgraded Texas Roadhouse from Neutral to Buy.
- B&G Foods, Inc. BGS shares gained 3.4 percent to $40.75. Credit Suisse upgraded B&G Foods from Neutral to Outperform.
- Tiffany & Co. TIF shares gained 2.7 percent to $92.36 after the company reported upbeat earnings for its fourth quarter.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in